Filtros de búsqueda

Lista de obras de Jordi Bruix

"Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?

artículo científico publicado en 2014

A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma ⬇️

artículo científico publicado el 12 de marzo de 2013

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

artículo científico publicado en 2013

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

artículo científico publicado en 2010

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

artículo científico publicado en 2006

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2010

A phase II trial of oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma.

artículo científico publicado en 2001

Abdominal drainage after liver resection for hepatocellular carcinoma in cirrhotic patients: a randomized controlled study

artículo científico publicado en 2004

Ablation for hepatocellular carcinoma: Is there need to have a winning technique?

artículo científico publicado en 2010

Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2015

Akt-mediated foxo1 inhibition is required for liver regeneration.

scientific article published on 16 October 2015

Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.

artículo científico publicado en 2009

Androgen receptors in hepatocellular carcinoma and surrounding liver: relationship with tumor size and recurrence rate after surgical resection

artículo científico publicado en 1995

Antiangiogenic therapy: not just for cancer anymore?

artículo científico publicado en 2009

Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma.

artículo científico publicado en 2018

Applicability of adult-to-adult living donor liver transplantation

artículo científico publicado en 2005

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

artículo científico publicado en 2002

Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors

artículo científico publicado en 2011

Assessment of treatment efficacy in hepatocellular carcinoma: Response rate, delay in progression or none of them.

artículo científico publicado en 2017

Authors' response to the letter: Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours or portal hypertension by Zhong et al.

artículo científico publicado en 2014

Benefits of laparoscopic liver resection in patients with hepatocellular carcinoma and portal hypertension: a case-matched study

artículo científico publicado en 2017

Bespoken nanoceria: A new effective treatment in experimental hepatocellular carcinoma

scientific article published on 21 January 2020

Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis.

artículo científico publicado en 1989

Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma

artículo científico publicado en 2019

Biomarkers for early diagnosis of hepatocellular carcinoma

artículo científico publicado en 2012

Biopsy for liver cancer: how to balance research needs with evidence-based clinical practice

article

Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study.

artículo científico publicado en 2013

Calcifications in the portal venous system: comparison of plain films, sonography, and CT

scientific article published on 01 August 1992

Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases

artículo científico publicado en 1991

Chemoembolization for intermediate HCC: Is there proof of survival benefit? ⬇️

artículo científico publicado el 17 de octubre de 2011

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics

artículo científico publicado en 2006

Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.

artículo científico publicado en 2009

Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers

artículo científico publicado en 2017

Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques

artículo científico

Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography.

artículo científico publicado en 2005

Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma

artículo científico publicado en 2011

Comparison of Intravenous Somatostatin and Vasopressin Infusions in Treatment of Acute Variceal Hemorrhage

scientific article published on 01 May 1984

Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events.

artículo científico publicado en 2017

Consideraciones acerca de la Conferencia de Barcelona sobre diagnóstico y tratamiento del carcinoma hepatocelular

artículo científico publicado en 2002

Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation

artículo científico publicado en 2003

Controversies in the management of hepatocellular carcinoma

scientific article published on 18 March 2019

Corrigendum to "Diagnosis and staging of hepatocellular carcinoma (HCC): Current guidelines" [Eur. J. Radiol. 101 (2018) 72-81]

scientific article published on 30 January 2019

Corrigendum to “Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies” [J hepatol 67 (2017) 999–1008]

scholarly article published in Journal of Hepatology

Corrigendum to: “FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program” [J Hepatol 2011;54:227–235]

scholarly article published in Journal of Hepatology

Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation ⬇️

artículo científico publicado el 1 de enero de 2002

Coxiella burnetti pericarditis. An exceptional disease

artículo científico publicado en 1988

Current strategy for staging and treatment: the BCLC update and future prospects.

artículo científico publicado en 2010

Design and endpoints of clinical trials in hepatocellular carcinoma.

artículo científico publicado en 2008

Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines

artículo científico publicado en 2018

Diagnosis and staging of hepatocellular carcinoma prior to transplantation: Expertise or failure

artículo científico publicado en 2006

Diagnosis and treatment of hepatocellular carcinoma

artículo científico publicado en 2009

Diagnosis and treatment of hepatocellular carcinoma.

artículo científico publicado en 1999

Diagnosis of Early Hepatocellular Carcinoma: Ideal Goal, But Not Yet There

artículo científico publicado en 2010

Diagnosis of Hepatic Nodules in Patients at Risk for Hepatocellular Carcinoma: LI-RADS Probability Versus Certainty

scientific article published on 15 February 2019

Diagnosis of Small HCC

artículo científico publicado en 2005

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

artículo científico publicado en 2008

Diagnostic accuracy of fine-needle aspiration biopsy in patients with hepatocellular carcinoma

artículo científico publicado en 1989

Diagnostic imaging and biopsy use among elderly medicare beneficiaries with hepatocellular carcinoma.

artículo científico publicado en 2011

Diagnóstico temprano del cáncer de hígado

scientific article published on 01 May 2005

Diarrhea as a presenting symptom of hepatocellular carcinoma

artículo científico publicado en 1990

Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis.

artículo científico publicado en 2006

Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.

artículo científico publicado en 2006

Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib

artículo científico publicado en 2014

Early diagnosis and treatment of hepatocellular carcinoma

artículo científico publicado en 2000

East meets the West--portal pressure predicts outcome of surgical resection for hepatocellular carcinoma

artículo científico publicado en 2008

Ecografía con contraste en el diagnóstico del carcinoma hepatocelular

scientific article published on 08 December 2012

Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis

scientific article published on 01 November 1984

Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis

artículo científico publicado en 1987

Effects of metoclopramide and domperidone on azygos venous blood flow in patients with cirrhosis and portal hypertension

artículo científico publicado en 1986

Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver.

artículo científico publicado en 1985

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial

artículo científico publicado en 2012

Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage

scientific article published on 01 March 1989

Esophageal dysfunction in primary biliary cirrhosis

artículo científico publicado en 1988

Evaluation of the portal hypertensive patient

artículo científico

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

artículo científico publicado en 2009

Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

artículo científico publicado en 2016

Evolving role of regorafenib for the treatment of advanced cancers

artículo científico publicado en 2020

Expanded Criteria for Hepatocellular Carcinoma Through Down-Staging Prior to Liver Transplantation: Not Yet There

article

Exposure-response relationship of regorafenib efficacy in patients with hepatocellular carcinoma

artículo científico publicado en 2017

FOLFOX-4 vs. doxorubicin for hepatocellular carcinoma: Could a negative result be accepted as positive?

artículo científico publicado en 2014

Failure of interferon to prevent disease progression and liver cancer in hepatitis C virus infection: proof of absence or absence of proof?

artículo científico publicado en 2009

FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program

artículo científico publicado en 2010

Fine-needle aspiration biopsy of portal vein thrombus: value in detecting malignant thrombosis

artículo científico publicado en 1993

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma

artículo científico publicado en 2008

Focus on hepatocellular carcinoma.

artículo científico publicado en 2004

Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma

artículo científico publicado en 2004

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

artículo científico publicado en 2008

Gene expression of endothelin-1 and ET(A) and ET(B) receptors in human cirrhosis: relationship with hepatic hemodynamics.

artículo científico publicado en 1998

Gene-expression signature of vascular invasion in hepatocellular carcinoma.

artículo científico publicado en 2011

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma

artículo científico publicado en 2007

Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma.

artículo científico publicado en 2017

HCC surveillance: Who is the target population?

artículo científico publicado en 2003

Hepatic Oncology: a journal for all stakeholders in liver cancer management.

artículo científico publicado en 2013

Hepatic fibrin-ring granulomas in a patient with hepatitis A.

artículo científico publicado en 1991

Hepatitis B virus and hepatocellular carcinoma

artículo científico publicado en 2003

Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma

artículo científico publicado en 1997

Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers

artículo científico

Hepatitis C virus infection in patients with nonalcoholic chronic liver disease

artículo científico publicado en 1990

Hepatitis G virus infection in chronic liver disease

artículo científico publicado en 1998

Hepatocellular Carcinoma (HCC)

artículo científico publicado en 2010

Hepatocellular Carcinoma and Cirrhosis

scientific article published on 01 March 1996

Hepatocellular Carcinoma: Paving the Road for Further Developments

scientific article published on 04 November 2014

Hepatocellular carcinoma

artículo científico publicado en 2003

Hepatocellular carcinoma

artículo científico publicado en 2018

Hepatocellular carcinoma and the art of prognostication

artículo científico publicado en 2000

Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipients

artículo científico publicado en 2005

Hepatocellular carcinoma in the setting of liver transplantation

article

Hepatocellular carcinoma: Current state of the art in diagnosis and treatment

artículo científico publicado en 2014

Hepatocellular carcinoma: clinical frontiers and perspectives

artículo científico publicado en 2014

Hepatocellular carcinoma: is surveillance cost effective?

artículo científico publicado en 2001

Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery

artículo científico publicado en 2014

High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.

artículo científico publicado en 2001

High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.

artículo científico publicado en 2004

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.

artículo científico publicado en 2010

Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy Tissues

scientific article published on 06 August 2019

Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma.

artículo científico publicado en 2003

If portal hypertension predicts outcome in cirrhosis, why should this not be the case after surgical resection?

artículo científico publicado en 2013

Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action

artículo científico publicado en 1998

Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: A randomized study

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

artículo científico publicado en 2001

Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases

artículo científico publicado en 1999

Inheriting a Jewel: A Thrilling Challenge

artículo científico publicado en 2016

Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

artículo científico publicado en 2004

Insights into the success and failure of systemic therapy for hepatocellular carcinoma

artículo científico publicado en 2019

Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers

artículo científico publicado en 2003

Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes

artículo científico publicado en 2013

Intermediate-stage HCC—upfront resection can be feasible

artículo científico publicado en 2015

International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis

artículo científico publicado en 2020

Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study.

artículo científico publicado en 2014

Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound

scientific article published on 01 June 2010

Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?

artículo científico publicado en 2006

LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions.

artículo científico publicado en 2014

Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.

artículo científico publicado en 2014

Lenvatinib: can a non-inferiority trial change clinical practice?

artículo científico publicado en 2018

Letter: are sorafenib-related adverse events associated with prolonged survival? Authors' reply

artículo científico publicado en 2020

Liver Cancer Emergence Associated with Antiviral Treatment: An Immune Surveillance Failure?

artículo científico publicado en 2017

Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.

artículo científico publicado en 2015

Liver Metastases From Gastric Adenocarcinoma Mimicking Multinodular Hepatocellular Carcinoma

Liver cancer: An evolving challenge reaching research maturity

artículo científico publicado en 2008

Liver cancer: Approaching a personalized care

artículo científico publicado en 2015

Liver cancer: Still a long way to go

artículo científico publicado en 2011

Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment.

artículo científico publicado en 2016

Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision

article

Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches

artículo científico publicado en 2017

Local and Regional Therapies for Hepatocellular Carcinoma

scientific article published on 18 June 2020

Locoregional treatment for hepatocellular carcinoma: From clinical exploration to robust clinical data, changing standards of care

Locoregional treatments for hepatocellular carcinoma

artículo científico publicado en 1999

Locoregional versus systemic therapy — robust positive data remain elusive

artículo científico publicado en 2018

MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation

artículo científico publicado en 2003

Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.

artículo científico publicado en 2011

Major achievements in hepatocellular carcinoma

artículo científico publicado en 2009

Management of HCC

artículo científico publicado en 2012

Management of hepatocellular carcinoma

artículo científico publicado en 2005

Management of hepatocellular carcinoma: An update

artículo científico publicado en 2011

Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis

scientific article published on 01 January 1985

Medical treatment for cholangiocarcinoma

scientific article published on 01 May 2019

Medical treatments: in association or alone, their roles and their future perspectives: the Western experience.

artículo científico publicado en 2009

Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma

artículo científico publicado en 2010

MicroRNA analysis for outcome prediction in hepatitis B virus-related liver cancer

artículo científico publicado en 2010

MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a

artículo científico publicado en 2011

Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial

artículo científico publicado en 2018

Molecular targeted therapies in hepatocellular carcinoma

artículo científico publicado en 2008

Multifaceted perspective of the waiting list for liver transplantation: the value of pharmacokinetic models

artículo científico publicado en 2010

Natural history of hepatocellular carcinoma in Spain

article

New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma

artículo científico publicado en 2013

New aspects of diagnosis and therapy of hepatocellular carcinoma.

artículo científico publicado en 2006

New drugs for the treatment of hepatocellular carcinoma.

artículo científico publicado en 2009

Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension

article

Non-invasive diagnosis of hepatocellular carcinoma ⩽2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI

artículo científico publicado en 2012

Nonsurgical treatment of hepatocellular carcinoma

artículo científico publicado en 2000

Orthotopic implantation of human hepatocellular carcinoma in mice: analysis of tumor progression and establishment of the BCLC-9 cell line.

artículo científico publicado en 2004

Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial

article by Richard S Finn et al published August 2018 in Journal of Hepatology

Pattern of tumor progression in liver cancer: The missing partner in trial design.

artículo científico publicado en 2015

Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy

artículo científico publicado en 2009

Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma

artículo científico publicado en 2019

Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication.

artículo científico publicado en 2017

Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials

artículo científico publicado en 2020

Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2013

Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials

artículo científico publicado en 1994

Pilot study of living donor liver transplantation for patients with HCC exceeding Milan criteria (BCLC extended criteria).

artículo científico publicado en 2017

Pivotal role of mTOR signaling in hepatocellular carcinoma

artículo científico publicado en 2008

Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis.

artículo científico

Portal pressure in patients with exudative ascites in the course of acute hepatitis B.

artículo científico publicado en 1991

Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design

artículo científico publicado en 2013

Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation

artículo científico publicado en 2019

Preoperative evaluation of biliary anatomy in adult live liver donors with volumetric mangafodipir trisodium enhanced magnetic resonance cholangiography

artículo científico publicado en 2004

Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis.

artículo científico publicado en 2000

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

artículo científico publicado en 1989

Prognosis of hepatocarcinoma in liver transplantation in cirrhotic patients

artículo científico publicado en 1997

Prognosis of hepatocellular carcinoma.

artículo científico publicado en 2002

Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies

artículo científico publicado en 2017

Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients

artículo científico publicado en 1990

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

artículo científico publicado en 2002

Prognostic prediction in patients with hepatocellular carcinoma.

artículo científico publicado en 2005

Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis

scientific article published on 28 May 2019

Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.

artículo científico publicado en 2015

Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma

artículo científico publicado en 2012

Pseudotumoral hepatic tuberculosis

artículo científico publicado en 2003

Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models

artículo científico publicado en 2020

Regorafenib and the RESORCE trial: a new second-line option for hepatocellular carcinoma patients

scientific article published on 19 August 2016

Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study

artículo científico publicado en 2013

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

artículo científico publicado en 2016

Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses

artículo científico publicado en 2012

Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma

scientific article published on 15 January 2020

Reply

artículo científico publicado en 2015

Reply

scientific article published on 30 July 2015

Reply to "Direct antiviral agents and risk for hepatocellular carcinoma (HCC) early recurrence: Much ado about nothing".

artículo científico publicado en 2016

Reply to: "Predictors of sorafenib benefit in patients with hepatocellular carcinoma".

artículo científico publicado en 2017

Reply to: "The reported 'clear cut time association between interferon-free treatment and HCC' is anything but clear cut"

scientific article published on 13 December 2019

Reply to: "Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules - A response"

artículo científico publicado en 2019

Reply to: ''Poor contrast enhanced ultrasonography! There is no limit to its decline in the diagnosis of hepatocellular carcinoma on cirrhosis!''.

artículo científico publicado en 2015

Reply:

artículo científico publicado en 2017

Response

Restoring miR122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through Smad-independent TGF-β pathway.

artículo científico publicado en 2016

Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience

artículo científico publicado en 2014

Risk factors for hepatocellular carcinoma in Catalonia, Spain

artículo científico publicado en 1990

Role of drug-dependent transporter modulation on the chemosensitivity of cholangiocarcinoma

artículo científico publicado en 2017

Rolling review: the treatment of major complications of cirrhosis.

artículo científico publicado en 1994

SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma.

artículo científico publicado en 2014

Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines

artículo científico publicado en 2012

Screening for Liver Cancer: The Rush to Judgment

artículo científico publicado en 2012

Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations

artículo científico publicado en 2012

Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine.

artículo científico publicado en 2014

Sex hormone receptors in hepatocellular carcinoma

artículo científico publicado en 1993

Sorafenib for hepatocellular carcinoma: global validation.

artículo científico publicado en 2009

Sorafenib in advanced hepatocellular carcinoma

artículo científico publicado en 2008

Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial.

artículo científico publicado en 2016

Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer

artículo científico publicado en 2015

Sunitinib and the benefits of a negative study.

artículo científico publicado en 2009

Surgical resection and survival in Western patients with hepatocellular carcinoma

artículo científico publicado en 1992

Surgical resection for hepatocellular carcinoma: Moving from what can be done to what is worth doing

artículo científico publicado en 2015

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

artículo científico publicado en 1996

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

artículo científico publicado en 2012

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

artículo científico publicado en 2003

Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib

artículo científico publicado en 2019

Systemic Treatment: Expecting Further Success

artículo científico publicado en 2015

Systemic therapy for hepatocellular carcinoma: the issue of treatment stage migration and registration of progression using the BCLC-refined RECIST.

artículo científico publicado en 2014

Systemic therapy for hepatocellular carcinoma: trial enrichment does not guarantee success

artículo científico publicado en 2018

Systemic treatment

artículo científico

Systemic treatment for advanced hepatocellular carcinoma: the search of new agents to join sorafenib in the effective therapeutic armamentarium.

artículo científico publicado en 2016

Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation

artículo científico publicado en 1988

Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis

artículo científico publicado en 1985

Testing molecular therapies in hepatocellular carcinoma: the need for randomized phase II trials

artículo científico publicado en 2009

The Search for an Effective Partner for Sorafenib: The Failure of Doxorubicin

artículo científico publicado en 2011

The Size of the Problem: Clinical Algorithms ⬇️

artículo científico publicado el 17 de junio de 2013

The challenges of novel contrast agents for the imaging diagnosis of hepatocellular carcinoma

artículo científico publicado en 2013

The current status of liver transplantation for primary hepatic malignancy.

artículo científico publicado en 2000

The impact of direct antiviral agents on the development and recurrence of hepatocellular carcinoma.

artículo científico publicado en 2017

The need for novel and interesting data in liver cancer research

artículo científico publicado en 2009

The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.

artículo científico publicado en 2011

The success of regorafenib in hepatocellular carcinoma in a world of failures. Learnings for future developments.

artículo científico publicado en 2017

Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules

scientific article published on 24 January 2019

Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET--letter

artículo científico publicado en 2013

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study

article

Tivantinib in MET-high hepatocellular carcinoma patients and the ongoing Phase III clinical trial

scientific article published on 29 January 2014

To Expand or Not to Expand the Criteria for Hepatocellular Carcinoma Transplantation: Is Downstaging the Answer?

artículo científico publicado en 2009

Toward a better liver graft allocation that accounts for candidates with and without hepatocellular carcinoma

artículo científico publicado en 2014

Transarterial chemoembolization for patients with hepatocellular carcinoma

artículo científico publicado en 2007

Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever.

artículo científico publicado en 1995

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

artículo científico publicado en 1998

Treating hepatitis C in patients with cirrhosis: the effort is worth it.

artículo científico publicado en 2010

Treatment approach of hepatocellular carcinoma in Spain. Analysis of 705 patients from 62 centers

artículo científico publicado en 2009

Treatment of Hepatocellular Carcinoma with Radioembolization: Gathering Assumptions for Trial Design

artículo científico publicado en 2013

Treatment of Hepatocellular Carcinoma.

artículo científico publicado en 2016

Treatment of advanced hepatocellular carcinoma

artículo científico publicado en 2010

Treatment of early hepatocellular carcinoma: Towards personalized therapy

artículo científico publicado en 2010

Treatment of hepatocellular carcinoma

artículo científico publicado en 2006

Treatment of hepatocellular carcinoma

artículo científico publicado en 1997

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

artículo científico publicado en 1995

Treatment of hepatocellular carcinoma.

artículo científico publicado en 2014

Treatment of hepatocellular carcinoma: is there an optimal strategy?

artículo científico publicado en 2003

Treatment of intermediate-stage hepatocellular carcinoma

artículo científico

Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection

scientific article published on 01 November 1993

Treatment strategies for hepatocellular carcinoma in cirrhosis.

artículo científico publicado en 2003

Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma.

artículo científico publicado en 2017

Tumor necrosis factor primes hepatocytes for DNA replication in the rat

article

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

artículo científico publicado en 1992

Two Decades of Advances in Hepatocellular Carcinoma Research

article

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

artículo científico publicado en 2016

Unresectable Hepatocellular Carcinoma: Meta-Analysis of Arterial Embolization [letter]

article

Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma (HCC) who progressed on sorafenib treatment

scientific article published on 01 June 2017

Usefulness of the molecular profile in the diagnosis, prognosis and treatment of hepatocellular carcinoma

artículo científico publicado en 2014

Value and limitations of cytologic criteria for the diagnosis of hepatocellular carcinoma by fine needle aspiration biopsy

artículo científico publicado en 1993

Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma

artículo científico publicado en 2015

Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.

artículo científico publicado en 2012

World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective

artículo científico publicado en 2010

[Early diagnosis of hepatocellular carcinoma: therapeutic implications]

artículo científico publicado en 1993

[Hepatocellular carcinoma and liver transplantation]

artículo científico publicado en 1995

[Intracardiac thrombosis, bacterial endocarditis and pulmonary thromboembolism as a complication of peritoneovenous shunt]

scientific article published on 01 May 1987

[Pharmacological treatment of digestive hemorrhage due to the rupture of esophageal varices]

artículo científico publicado en 1984

[Streptococcus agalactiae infection in patients with hepatic cirrhosis]

artículo científico publicado en 1989

c-met mRNA overexpression in human hepatocellular carcinoma

artículo científico publicado en 1994

nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma

artículo científico publicado en 1994

p27Kip1 is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma

artículo científico publicado en 2003

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda